Bone Marrow

Renewed interest in CAR-T therapies makes the market a hot one.

CAR-T race heats up with flurry of new deals

By Zachary Brennan

The hype around developing new CAR-T (Chimeric Antigen Receptor transduced T) cell therapies, which can fight cancers by modifying patients’ immune cells, seemed to hit a new high this week, with two partnerships and an acquisition.